ASCO to shine light on CAR-T developments
May 19, 2017Kite, Juno, and BlueBird will give updates on T-cell therapies.
X
ASCO to shine light on CAR-T developments
https://pharmaphorum.com/news/asco-shine-light-car-t-developments/
blood cancer
NICE backs Amgen’s Blincyto in rare leukaemia
May 2, 2017Drug will also be available to children via Cancer Drugs Fund.
Novartis and Allergan to combine drugs in NASH
April 18, 2017Swiss pharma also aims for new CAR-T therapy indication.
Novartis edges ahead in CAR-T race
March 30, 2017
Keytruda in new lymphoma use leads latest CHMP decisions
March 27, 2017MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
NICE rejects Opdivo in blood cancer, asks for more data
March 15, 2017Merck’s rival Keytruda gets new US indication.
Celgene files AML pill after fast-track trial
March 2, 2017The FDA has accepted Celgene’s filing for enasidenib.
Truxima, world’s first cancer drug biosimilar approved in Europe
February 22, 2017Roche’s top seller faces rival four years after patent expiry
Pfizer’s fast-tracked leukaemia candidate could rival CAR-Ts
February 22, 2017Antibody-drug conjugate with FDA gets six-month review.
